Bone Biologics Corp (BBLG)
1.80
-0.01
(-0.55%)
USD |
NASDAQ |
May 09, 15:30
Bone Biologics Net Income (Quarterly): -1.550M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.550M |
September 30, 2023 | -1.920M |
June 30, 2023 | -1.769M |
March 31, 2023 | -3.710M |
December 31, 2022 | 0.8935M |
September 30, 2022 | -1.219M |
June 30, 2022 | -0.4693M |
March 31, 2022 | -0.6895M |
December 31, 2021 | -0.1777M |
September 30, 2021 | -0.5093M |
June 30, 2021 | -0.4919M |
March 31, 2021 | -0.4317M |
December 31, 2020 | -0.4537M |
September 30, 2020 | -0.394M |
June 30, 2020 | -0.38M |
March 31, 2020 | -0.5969M |
December 31, 2019 | -0.5311M |
September 30, 2019 | -0.5614M |
Date | Value |
---|---|
June 30, 2019 | -0.9256M |
March 31, 2019 | -1.407M |
December 31, 2018 | -1.471M |
September 30, 2018 | -0.2417M |
June 30, 2018 | -1.263M |
March 31, 2018 | -1.455M |
December 31, 2017 | -2.770M |
September 30, 2017 | -2.376M |
June 30, 2017 | 1.016M |
March 31, 2017 | -2.922M |
December 31, 2016 | -9.728M |
September 30, 2016 | -4.372M |
June 30, 2016 | -4.800M |
March 31, 2016 | -6.978M |
December 31, 2015 | -7.981M |
September 30, 2015 | -3.363M |
June 30, 2015 | -0.8908M |
March 31, 2015 | -1.642M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.710M
Minimum
Mar 2023
0.8935M
Maximum
Dec 2022
-0.8361M
Average
-0.5311M
Median
Dec 2019
Net Income (Quarterly) Benchmarks
ThermoGenesis Holdings Inc | -7.014M |
BioVie Inc | -8.401M |
Krystal Biotech Inc | 0.932M |
Adial Pharmaceuticals Inc | -1.920M |
NovaBay Pharmaceuticals Inc | -4.108M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 1.16M |
EPS Diluted (Quarterly) | -2.901 |
Enterprise Value | -2.060M |
Earnings Yield | -4.25K% |